Submit your Center of Excellence Application today!

Read More


Feb 25, 2019

Newt Gingrich: Incredible medical breakthroughs coming to cure diseases and save lives

Newt Gingrich: Incredible medical breakthroughs coming to cure diseases and save lives

By: Newt Gingrich

There has been astonishing medical progress in recent years and we can expect more  soon.

The second wave of breakthroughs occurred with the introduction of statins, treatments for HIV/AIDS, and the refinement of chemotherapy drugs in the 1990s.


Since that time, however, we’ve generally seen a period of incremental progress with few huge breakthroughs.

To be clear: This steady improvement in established fields of pharmacology has helped expand our understanding and provided more effective treatments to people with a variety of diseases. Steady and meaningful incremental improvement is still definitely positive.

After all, if a treatment helps a patient live six months longer than he or she would without the treatment, those six months of life are still significant.

Yet some have criticized this period of incremental improvement as evidence that something is broken in the medical-pharmaceutical field.

Every month, someone writes an analysis describing an “innovation crisis” in the industry because the number of so-called blockbuster drugs is declining. In fact, those inclined to conspiracy theories hold that there is a perverse incentive to treat rather than cure diseases, because treatments are more profitable.

The truth is much simpler: Science takes time. Developing new drugs and treatments does as well. The reason we have seemed stuck in a period of incremental progress is because the most promising new fields for breakthroughs have been in their infancy.

Fortunately, this appears to be changing.

The past two years have shown signs of astonishing progress in the field of gene therapy. We have every reason to believe we are at the beginning of the third wave of medical breakthroughs.

Read more:

Source: Fox News

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.